Rephonic
Artwork for Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech 2050
Biotechnology
Oncology
Cell Therapy
Ophthalmology
Gene Therapy
Aging Biology
Biotech
KRAS G12V
Venture Capital
Precision Medicine
Microglia
Cancer Metastasis
AI In Drug Development
Drug Discovery
Cystic Fibrosis
Clinical Trials
Gene Editing
Precision Oncology
Breast Cancer
Sloan Kettering

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

PublishesWeeklyEpisodes254Founded6 years ago
Number of ListenersCategory
Science

Listen to this Podcast

Artwork for Biotech 2050 Podcast

Latest Episodes

Synopsis: From managing a theme park in Canada to leading the U.S. business of one of the world’s largest privately held pharma companies, Brian Hilberdink’s journey is anything but conventional. Live from JPM 2026 in San Francisco, Biotech 2050 host... more

Synopsis: Fresh from the JPM 2026 in San Francisco, Alok Tayi welcomes Johan Luthman, Executive Vice President of R&D at Lundbeck, for a sweeping, deeply personal conversation on the future of neuroscience drug development. From his early days as a S... more

Synopsis: At a moment when biotech is rethinking growth, innovation, and patient impact, Alok Tayi sits down with Christophe Bourdon, Chief Executive Officer of LEO Pharma, to explore what it truly means to build a purpose-driven, commercial-stage bi... more

Synopsis: This episode is proudly sponsored by Quartzy. Roivant Sciences CEO Matt Gline returns to Biotech 2050 for a deeply reflective conversation with host Rahul Chaturvedi on what it really takes to build a biotech company that lasts. From Roivan... more

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

Johan Luthman
EVP of R&D at Lundbeck
Lundbeck
Episode: Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery
Christophe Bourdon
CEO of LEO Pharma
LEO Pharma
Episode: Christophe Bourdon, LEO Pharma CEO, on Dermatology Innovation, Rare Disease & Scalable Growth
Matt Gline
CEO of Roivant Sciences
Roivant Sciences
Episode: Matt Gline, Roivant Sciences CEO, on Clinical Breakthroughs, Capital Discipline & Building Biotech
Jay Hartenbach
President and COO of Diakonos Oncology
Diakonos Oncology
Episode: Jay Hartenbach, President & COO, Diakonos Oncology on Reprogramming Cancer Immunity Breakthrough
John Lepore
CEO of ProFound Therapeutics and CEO Partner at Flagship Pioneering
ProFound Therapeutics
Episode: John Lepore, CEO & President - ProFound Therapeutics, on Proteome, AI, & Bold First-in-Class Drugs
Jason Kelly
CEO and co-founder of Ginkgo Bioworks
Ginkgo Bioworks
Episode: Jason Kelly - Ginkgo Bioworks CEO and Co-Founder on Automation, AI Data & Biotech’s Reset
Arun Swaminathan
CEO of Coya Therapeutics
Coya Therapeutics
Episode: Arun Swaminathan: Coya CEO on Neuroinflammation, BD Strategy & Patient-Driven Biotech
Abbas Kazimi
CEO of Nimbus Therapeutics
Nimbus Therapeutics
Episode: How Nimbus CEO Abbas Kazimi Builds Resilient Pipelines Through Culture, Rigor & Smart Bets
Jim Tananbaum
Founder and CEO of Foresite Capital
Foresite Capital
Episode: Foresite Capital’s Jim Tananbaum on Biotech Cycles, AI Breakthroughs & Long-Term Value

Hosts

Rahul Chaturvedi
Co-founder of the podcast and today's host
Alok Tayi
CEO and co-founder of VibeBio

Reviews

4.8 out of 5 stars from 177 ratings
  • Wonderful Diversity of Leadership

    Bravo! From patient focus, to capital formation, to commercial expertise… these conversations are engaging and meaningful to the bio ecosystem.

    Apple Podcasts
    5
    Sae36
    United States2 years ago
  • Sounds like a sales pitch

    I was hoping to hear about some interesting technology, but the first 20 minutes sounded like a sales pitch and slagging competitors. I ran out of patience so couldn’t finish it.

    Apple Podcasts
    1
    John-Hernry2
    Australia5 years ago
  • Intense knowledge to absorb

    Very well done podcast with tons of information that sounds like a freaking french to me but, after while you listening the podcast, you'll realize that you are smarter than before... damn... keep up the good work...

    Apple Podcasts
    5
    bimmerx
    Canada5 years ago
  • Finally!

    Love where this is going, been looking for a podcast to keep me up on the latest and greatest happenings in biotech.

    Apple Podcasts
    5
    TR-iumph
    United States6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate the engaging and meaningful conversations that touch upon diverse topics within the biotechnology ecosystem.
Overall, many find the content to be informative and enlightening, often gaining valuable insights into the biotech sector.
Some listeners have expressed frustration with episodes that come across as overly promotional or sales-focused rather than informative.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#121
Japan/Science
Apple Podcasts
#146
South Korea/Science
Apple Podcasts
#193
India/Science
Apple Podcasts
#216
New Zealand/Science
Apple Podcasts
#225
Israel/Science
Apple Podcasts
#240
Taiwan/Science

Talking Points

Recent interactions between the hosts and their guests.

Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery
Q: What are the challenges and opportunities in the rare disease space?
Rare diseases entail high-touch clinical trial models, which demand more direct patient interaction but also provide invaluable insights that strengthen patient relationships and improve treatment outcomes.
Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery
Q: How does Lundbeck plan to use AI in their R&D processes?
Lundbeck is focusing on four areas in R&D, including collaboration in finding molecules and building a better data infrastructure to prepare for generative AI applications in protocol documentation.
Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery
Q: What is the significance of the portfolio changes and the growth perspective for Lundbeck in the next five to ten years?
Lundbeck aims to grow its portfolio by focusing on breakthrough opportunities and fostering external innovation while maintaining a disciplined approach to new strategic acquisitions.
Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier
Q: How does the principle and execution of a commercial organization evolve in the next 10 to 20 years?
The future lies in finding innovative ways to ensure patients have access to medications, such as developing direct-to-consumer distribution channels, especially in markets like obesity.
Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier
Q: What does the future look like for Boehringer?
Boehringer is positioned uniquely as the world's largest privately held pharmaceutical company, focusing on long-term health innovations and investing significantly in R&D to support upcoming product launches.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Biotech 2050 Podcast

What is Biotech 2050 Podcast about and what kind of topics does it cover?

Focused on the disruptions reshaping the biotechnology sector, discussions center around innovations, advancements, and the evolving landscape of drug development. Topics often include insights from industry leaders regarding AI's role in biotech, regulatory frameworks, and the importance of patient-centric approaches in therapeutic strategies. The podcast features extensive conversations with CEOs and thought leaders who share their experiences and visions for the future of biotechnology, allowing listeners to gain a deep understanding of current challenges and opportunities within the industry.

Where can I find podcast stats for Biotech 2050 Podcast?

Rephonic provides a wide range of podcast stats for Biotech 2050 Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Biotech 2050 Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Biotech 2050 Podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Biotech 2050 Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Biotech 2050 Podcast?

Rephonic provides comprehensive predictive audience data for Biotech 2050 Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Biotech 2050 Podcast have?

To see how many followers or subscribers Biotech 2050 Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Biotech 2050 Podcast?

These podcasts share a similar audience with Biotech 2050 Podcast:

1. The Readout Loud
2. Business Of Biotech
3. Biotech Hangout
4. BioCentury This Week
5. The Long Run with Luke Timmerman

How many episodes of Biotech 2050 Podcast are there?

Biotech 2050 Podcast launched 6 years ago and published 254 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Biotech 2050 Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Biotech 2050 Podcast?

Rephonic pulls ratings and reviews for Biotech 2050 Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Biotech 2050 Podcast?

Rephonic provides full transcripts for episodes of Biotech 2050 Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Biotech 2050 Podcast?

Recent guests on Biotech 2050 Podcast include:

1. Johan Luthman
2. Christophe Bourdon
3. Matt Gline
4. Jay Hartenbach
5. John Lepore
6. Jason Kelly
7. Arun Swaminathan
8. Abbas Kazimi

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days